MedTrace Logo

Registry Experience at the Washington Hospital Center, DES - Endeavor for Myocardial Infarction

NCT01003717 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2020-01-02

No results posted yet for this study

Summary

Single-center registry of patients treated with at least one Endeavor, zotarolimus-eluting, Stent as the primary treatment for acute coronary syndrome at the Washington Hospital Center, with the aim of assessing clinical success and safety at 30 days, 6 months and annually for up to 3 years post Endeavor Stent implantation.

Conditions

Sponsors & Collaborators

  • Rebecca Torguson

    lead OTHER

Principal Investigators

  • Ron Waksman, MD · Medstar Research Institute/Cardiovascular Research Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2011-10-31
Completion
2013-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01003717 on ClinicalTrials.gov